1. State of play endocrine disruptors
75th CA meeting
23-24 November 2017 1

2. Introduction Published delegated regulation CA documents
Technical guidance
Screening study IA 2

3. Commission Delegated Regulation (EU) 2017/2100
Published 17 November 2017 in OJ
Regulation enters into force on the twentieth day following publication
The criteria shall apply from 7 June 2018
Link to OJ for all language versions: content/EN/TXT/?qid= &uri=CELEX:32017R2100. 3

4. 2. Secondary legislation and regulatory guidance
Implementation
1. CA notes for agreement
2. Secondary legislation and regulatory guidance
3. Technical and Scientific guidance ED
Criteria

5. CA notes ED Criteria Delegated act Approved active substances
On- going procedures active substances
Already authorised and on- going procedures biocidal products ED
Criteria
Delegated act

6. Update on ED-guidance development
10th ED Expert Group meeting
15/16 November 2017

7. Member States & Stakeholders
Drafting team and consultation group
Drafting team:
ECHA, EFSA, JRC
EFSA
PPP Experts
Member States & Stakeholders
ECHA ED expert group
Consultation group

8. Guidance development process – to date
Draft guidance for public consultation (Nov 2017)
2nd Consultation Group commenting (July-Aug 2017)
Second draft
1st Consultation Group commenting (Apr-May 2017)
First draft (Jan 2017)

9. Guidance development process – to come
Endorsement and publication of Guidance for ED identification (May 2018)
Finalisation of Guidance (April 2018)
Consultation of competent scientific bodies (e.g. BPC)
Evaluation of comments - revision of Guidance (February - March 2018)
Public consultation (December 2017 – January 2018)
Guidance for ED identification planned to be available once ED criteria for BP become applicable

10. Workshop ECHA and EFSA presenting draft guidance
Case studies (experiences with applying the draft guidance to active substance dossiers)
Joint meeting BPs and PPPs
End of January/beginning February 10

11. Screening study IA 11